Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2001-2-15
pubmed:abstractText
Low-molecular-weight heparins are frequently used to treat venous thromboembolism, but optimal dosing regimens and clinical outcomes need further definition.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0028-4793
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
344
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
626-31
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11228276-Acute Disease, pubmed-meshheading:11228276-Anticoagulants, pubmed-meshheading:11228276-Drug Administration Schedule, pubmed-meshheading:11228276-Female, pubmed-meshheading:11228276-Hemorrhage, pubmed-meshheading:11228276-Heparin, pubmed-meshheading:11228276-Heparin, Low-Molecular-Weight, pubmed-meshheading:11228276-Humans, pubmed-meshheading:11228276-Infusions, Intravenous, pubmed-meshheading:11228276-Injections, Subcutaneous, pubmed-meshheading:11228276-Male, pubmed-meshheading:11228276-Middle Aged, pubmed-meshheading:11228276-Neoplasms, pubmed-meshheading:11228276-Pulmonary Embolism, pubmed-meshheading:11228276-Recurrence, pubmed-meshheading:11228276-Single-Blind Method, pubmed-meshheading:11228276-Thrombocytopenia, pubmed-meshheading:11228276-Thromboembolism, pubmed-meshheading:11228276-Thrombosis
pubmed:year
2001
pubmed:articleTitle
Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
pubmed:affiliation
International Institute of Thrombosis and Vascular Diseases, Frankfurt, Germany. breddin@em.uni-frankfurt.de
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study